Decision Resources Inc. unveils 'cohesive' site

In an effort to create a more cohesive online experience for its potential clients, Decision Resources Inc. launched www.DecisionResourcesInc.com. 

The website features access and links to each of the six major companies under the Decision Resources Inc. umbrella: HealthLeaders Interstudy, Millennium Research Group, Arlington Medical Resources (AMR), Manhattan Research, Fingertip Formulary and the flagship, Decision Resources. 

“As the number of acquisitions grew, it became critical to define who the parent company of these premier market research providers was and show the market the cohesive threads that link each company,” said Elizabeth Marshall, director of marketing at Decision Resources. “The objectives of this website are to properly define Decision Resources Inc. for the investor and financial services communities as well as current and future clients,” Marshall said.

In addition to the new comprehensive website, Decision Resources Inc. will also maintain each of the six company's individual websites. 

“It is important that we maintain individually branded websites for each of the business units that go into much more detail about their products and services as well as serve as gateways into electronic products for many of the units,” said Marshall, adding that “information on analysts across all business units who have been quoted in major publications will be highlighted on the website too.” 

The website was designed in collaboration with Cramer, an ad agency.   

You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.